International journal of cardiology最新文献

筛选
英文 中文
Comment on: Cardiopulmonary remodeling following repetitive acute pulmonary emboli and inhibition of endogenous fibrinolysis in a porcine model. 评论:猪模型中重复性急性肺栓塞和内源性纤维蛋白溶解抑制后的心肺重塑。
IF 3.2 2区 医学
International journal of cardiology Pub Date : 2025-06-20 DOI: 10.1016/j.ijcard.2025.133546
Yan Yuehua, Miao Jia, Yang Yang
{"title":"Comment on: Cardiopulmonary remodeling following repetitive acute pulmonary emboli and inhibition of endogenous fibrinolysis in a porcine model.","authors":"Yan Yuehua, Miao Jia, Yang Yang","doi":"10.1016/j.ijcard.2025.133546","DOIUrl":"https://doi.org/10.1016/j.ijcard.2025.133546","url":null,"abstract":"","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":" ","pages":"133546"},"PeriodicalIF":3.2,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144368834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to: Letter to the editor: Prediction of adverse cardiovascular events in children using artificial intelligence-based electrocardiogram 回复:致编辑的信:基于人工智能的心电图预测儿童心血管不良事件。
IF 3.2 2区 医学
International journal of cardiology Pub Date : 2025-06-20 DOI: 10.1016/j.ijcard.2025.133540
Yoshitsugu Nogimori , Ryo Inuzuka
{"title":"Reply to: Letter to the editor: Prediction of adverse cardiovascular events in children using artificial intelligence-based electrocardiogram","authors":"Yoshitsugu Nogimori , Ryo Inuzuka","doi":"10.1016/j.ijcard.2025.133540","DOIUrl":"10.1016/j.ijcard.2025.133540","url":null,"abstract":"","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":"438 ","pages":"Article 133540"},"PeriodicalIF":3.2,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144368838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the potential role of Loganin in modulating JAK2/STAT3 signaling pathway in atherosclerosis 探讨罗甘素在动脉粥样硬化中调控JAK2/STAT3信号通路的潜在作用。
IF 3.2 2区 医学
International journal of cardiology Pub Date : 2025-06-20 DOI: 10.1016/j.ijcard.2025.133549
Sisi Li , Xiaogang Li , Yanmin Song
{"title":"Exploring the potential role of Loganin in modulating JAK2/STAT3 signaling pathway in atherosclerosis","authors":"Sisi Li , Xiaogang Li , Yanmin Song","doi":"10.1016/j.ijcard.2025.133549","DOIUrl":"10.1016/j.ijcard.2025.133549","url":null,"abstract":"","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":"438 ","pages":"Article 133549"},"PeriodicalIF":3.2,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144368835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-cardioversion anticoagulation in atrial fibrillation with left atrial appendage occlusion: Necessary or not? 左心耳闭塞的房颤转复后抗凝:是否有必要?
IF 3.2 2区 医学
International journal of cardiology Pub Date : 2025-06-19 DOI: 10.1016/j.ijcard.2025.133518
Sittinun Thangjui , Angkawipa Trongtorsak , Jakrin Kewcharoen , Sudarshan Balla , Sandeep Arora , David Schwartzman
{"title":"Post-cardioversion anticoagulation in atrial fibrillation with left atrial appendage occlusion: Necessary or not?","authors":"Sittinun Thangjui ,&nbsp;Angkawipa Trongtorsak ,&nbsp;Jakrin Kewcharoen ,&nbsp;Sudarshan Balla ,&nbsp;Sandeep Arora ,&nbsp;David Schwartzman","doi":"10.1016/j.ijcard.2025.133518","DOIUrl":"10.1016/j.ijcard.2025.133518","url":null,"abstract":"<div><h3>Background</h3><div>The role of post-cardioversion oral anticoagulation (OAC) in patients with atrial fibrillation (AF) and left atrial appendage occlusion (LAAO) remains unclear. Limited evidence exists regarding stroke, systemic thromboembolism (SSTEs), and bleeding risks in this population.</div></div><div><h3>Objective</h3><div>To evaluate the clinical outcomes following electrical cardioversion (eCVN) in patients with AF and prior LAAO.</div></div><div><h3>Methods</h3><div>We conducted a retrospective cohort study using the TriNetX Research Network to identify patients with prior surgical or percutaneous LAAO, no history of stroke, and no OAC use for at least 1 month prior to eCVN for AF between January 1, 2014, and November 1, 2024. Propensity score matching (PSM) was used to compare outcomes between those who received ≥1 month of OAC post-cardioversion (AC group) and those who did not (Non-AC group). Primary outcomes were SSTEs and significant bleeding.</div></div><div><h3>Results</h3><div>Among 1507 eligible patients, 583 (38.7 %) received post-cardioversion OAC. After PSM, 551 patients per group were analyzed. The AC group had a numerically lower but not statistically significant rate of SSTEs (OR 0.59, 95 % CI: 0.31–1.13) and ischemic stroke/transient ischemic attack (OR 0.69, 95 % CI: 0.35–1.92). Significant bleeding was similar between groups (6.0 % vs. 5.3 %; OR 1.15, 95 % CI: 0.67–1.92).</div></div><div><h3>Conclusion</h3><div>Among patients with AF and prior surgical and percutaneous LAAO undergoing cardioversion, post-procedure OAC use was not associated with significant differences in SSTEs or bleeding risk. Prospective studies are warranted to inform clinical guidelines.</div></div>","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":"438 ","pages":"Article 133518"},"PeriodicalIF":3.2,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144340083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to “Growth differentiation factor 15 and empagliflozin in acute myocardial infarction: Correspondence” 回复“生长分化因子15与依帕列净在急性心肌梗死中的对应关系”。
IF 3.2 2区 医学
International journal of cardiology Pub Date : 2025-06-19 DOI: 10.1016/j.ijcard.2025.133531
Óscar M. Peiró , Alfredo Bardají , Anna Carrasquer , German Cediel , Isabel Serrano , Gil Bonet , María Ferrero , Víctor Del-Moral-Ronda , Mar Rocamora-Horrach , José Luis Ferreiro
{"title":"Reply to “Growth differentiation factor 15 and empagliflozin in acute myocardial infarction: Correspondence”","authors":"Óscar M. Peiró ,&nbsp;Alfredo Bardají ,&nbsp;Anna Carrasquer ,&nbsp;German Cediel ,&nbsp;Isabel Serrano ,&nbsp;Gil Bonet ,&nbsp;María Ferrero ,&nbsp;Víctor Del-Moral-Ronda ,&nbsp;Mar Rocamora-Horrach ,&nbsp;José Luis Ferreiro","doi":"10.1016/j.ijcard.2025.133531","DOIUrl":"10.1016/j.ijcard.2025.133531","url":null,"abstract":"","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":"438 ","pages":"Article 133531"},"PeriodicalIF":3.2,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144340084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sex-specific response to cardiac resynchronization therapy: the BIO|WOMEN trial. 心脏再同步化治疗的性别特异性反应:BIO|WOMEN试验。
IF 3.2 2区 医学
International journal of cardiology Pub Date : 2025-06-19 DOI: 10.1016/j.ijcard.2025.133526
Jose Luis Zamorano, Gabor Vörös, Valeria Calvi, Joaquín Osca, Aurelio Quesada, Kevin Vernooy, Juan Gabriel Martinez, Alexander H Maass, Eyal Nof, Jose Maria Tolosana, Mónica Pardo, Craig Barr, Ignacio Fernández, Jose Luis Merino, Susan Ellery, Enrique Ricoy-Martínez, Giuseppina Belotti, Lea Seidlmayer, Santiago Garcia, Tobias Tönnis, Niall G Campbell, Paul Foley, Johannes Brockmeier, Michael Nürnberg, Ricardo Ruiz-Granell, Frits W Prinzen, Álvaro Lorente-Ros, Alicia Moreno, Mariona Pinart, Mark Ver Heyen, Lieselot Van Erven
{"title":"Sex-specific response to cardiac resynchronization therapy: the BIO|WOMEN trial.","authors":"Jose Luis Zamorano, Gabor Vörös, Valeria Calvi, Joaquín Osca, Aurelio Quesada, Kevin Vernooy, Juan Gabriel Martinez, Alexander H Maass, Eyal Nof, Jose Maria Tolosana, Mónica Pardo, Craig Barr, Ignacio Fernández, Jose Luis Merino, Susan Ellery, Enrique Ricoy-Martínez, Giuseppina Belotti, Lea Seidlmayer, Santiago Garcia, Tobias Tönnis, Niall G Campbell, Paul Foley, Johannes Brockmeier, Michael Nürnberg, Ricardo Ruiz-Granell, Frits W Prinzen, Álvaro Lorente-Ros, Alicia Moreno, Mariona Pinart, Mark Ver Heyen, Lieselot Van Erven","doi":"10.1016/j.ijcard.2025.133526","DOIUrl":"10.1016/j.ijcard.2025.133526","url":null,"abstract":"<p><strong>Background: </strong>Variable evidence exists about the efficacy of Cardiac resynchronization therapy (CRT) in women vs. men with reduced left ventricular ejection fraction (LVEF) and wide QRS complex. Current guidelines, hindered by underrepresentation of women in clinical trials, lack definitive recommendations. The present study was designed to achieve an equal distribution of women and men to prospectively evaluate sex-specific response to CRT.</p><p><strong>Methods: </strong>The primary endpoint was the absolute increase in core-lab-assessed LVEF 12 months after de novo implantation of a CRT device. Estimation was adjusted by several baseline confounders to correct sex-specific effect of CRT. Secondary endpoints were further echocardiographic changes including responder rate (LVEF increase ≥5 %); change in NYHA class, 6-min walk distance, quality of life, a clinical composite score (CCS) and the composite of death or HF hospitalization.</p><p><strong>Results: </strong>We enrolled 230 women and 244 men at 25 sites in eight countries. A larger improvement in LVEF (+14.7 % vs. +11.5 %, p ≤ 0.01) in women remained after adjustment for baseline variables (absolute increase attributed to female sex +2.53 %, P = 0.023). Furthermore, a better improvement was observed in reverse remodeling, responder rate (∆LVEF ≥5 %: 83.3 % vs. 70.6 %; p = 0.003), quality of life and HF symptoms in women compared to men. The CCS and the composite of death or HF hospitalization were better in women than in men after CRT.</p><p><strong>Conclusions: </strong>The effect of CRT remained superior in women regarding echocardiographic outcomes even after adjusting for baseline variables. Our results confirm the importance of recognizing sex-specific differences when screening patients for CRT.</p>","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":" ","pages":"133526"},"PeriodicalIF":3.2,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144340093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic value of CMR-derived extracellular volume in myocardial infarction with non-obstructive coronary arteries cmr衍生的细胞外体积对非阻塞性冠状动脉心肌梗死的预后价值
IF 3.2 2区 医学
International journal of cardiology Pub Date : 2025-06-18 DOI: 10.1016/j.ijcard.2025.133528
Lei Chen , Liqi Ge , Fuad A. Abdu , Xinjia Du , Jiahua Liu , Wensu Chen , Yuan Lu , Wenliang Che
{"title":"Prognostic value of CMR-derived extracellular volume in myocardial infarction with non-obstructive coronary arteries","authors":"Lei Chen ,&nbsp;Liqi Ge ,&nbsp;Fuad A. Abdu ,&nbsp;Xinjia Du ,&nbsp;Jiahua Liu ,&nbsp;Wensu Chen ,&nbsp;Yuan Lu ,&nbsp;Wenliang Che","doi":"10.1016/j.ijcard.2025.133528","DOIUrl":"10.1016/j.ijcard.2025.133528","url":null,"abstract":"<div><h3>Background</h3><div>Cardiac magnetic resonance (CMR) is crucial for diagnosing myocardial infarction with non-obstructive coronary arteries (MINOCA) and is recommended by current guidelines for its diagnostic and prognostic capabilities. However, the prognostic value of CMR parameters, particularly extracellular volume (ECV), in predicting major adverse cardiovascular events (MACE) among MINOCA remains unclear. This study analyzes ECV distribution across different MINOCA etiologies and its predictive value for MACE in “true” MINOCA.</div></div><div><h3>Methods</h3><div>Consecutive patients with a working diagnosis of MINOCA who underwent CMR were included. We investigated the relationships between CMR parameters and MACE in “true” MINOCA. Cox regression and ROC curve analyses were used to assess ECV in predicting MACE. “True” MINOCA was defined by evidence of ischemia or infarction on CMR.</div></div><div><h3>Results</h3><div>Among 275 patients with a working diagnosis of MINOCA (median 4 days to CMR), 96 were diagnosed with “true” MINOCA, 66 with myocarditis, 31 with Takotsubo syndrome (TS), 34 with cardiomyopathies, and 48 had normal findings. “True” MINOCA had higher ECV compared to other etiologies (29.10 % vs. 26.00 %, <em>P</em> &lt; 0.001). During a median follow-up of 26.6 months, 29.2 % of “true” MINOCA patients experienced MACE. In the adjusted Cox model, ECV (HR 1.063, 95 % CI 1.019–1.108, <em>P</em> = 0.004) was an independent predictor of MACE in patients with “true” MINOCA. According to optimal cut-off values from ROC, patients with ECV &gt;28.94 % had a significantly higher MACE risk (log-rank <em>P</em> &lt; 0.001).</div></div><div><h3>Conclusions</h3><div>CMR-derived ECV varies by MINOCA etiology, with higher levels in “true” MINOCA. Elevated ECV independently predicts increased MACE risk in “true” MINOCA patients.</div><div>Trial registration number: <span><span>ClinicalTrials.gov</span><svg><path></path></svg></span> (ID: <span><span>NCT06502899</span><svg><path></path></svg></span>).</div></div>","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":"437 ","pages":"Article 133528"},"PeriodicalIF":3.2,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144321164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Target, track, treat: Evolving paradigms in cardiovascular molecular imaging. 目标,跟踪,治疗:心血管分子成像的进化范式。
IF 3.2 2区 医学
International journal of cardiology Pub Date : 2025-06-18 DOI: 10.1016/j.ijcard.2025.133539
Brijesh Sathian, Javed Iqbal, Syed Muhammad Ali, Khadija Said Hamood Al Shukaili
{"title":"Target, track, treat: Evolving paradigms in cardiovascular molecular imaging.","authors":"Brijesh Sathian, Javed Iqbal, Syed Muhammad Ali, Khadija Said Hamood Al Shukaili","doi":"10.1016/j.ijcard.2025.133539","DOIUrl":"10.1016/j.ijcard.2025.133539","url":null,"abstract":"","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":" ","pages":"133539"},"PeriodicalIF":3.2,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144336501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on “Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A nationwide study” 《二尖瓣再手术与首次手术治疗二尖瓣反流的结果:一项全国性研究》评论
IF 3.2 2区 医学
International journal of cardiology Pub Date : 2025-06-18 DOI: 10.1016/j.ijcard.2025.133534
Aabir Imran , Aaila Haider
{"title":"Comment on “Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A nationwide study”","authors":"Aabir Imran ,&nbsp;Aaila Haider","doi":"10.1016/j.ijcard.2025.133534","DOIUrl":"10.1016/j.ijcard.2025.133534","url":null,"abstract":"","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":"438 ","pages":"Article 133534"},"PeriodicalIF":3.2,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144365392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "The efficacy and safety of dapagliflozin in pediatric heart failure". 对“达格列净治疗小儿心力衰竭的疗效和安全性”的评论。
IF 3.2 2区 医学
International journal of cardiology Pub Date : 2025-06-18 DOI: 10.1016/j.ijcard.2025.133537
Yuting Song, Qiang Shi, Chengzhi Xu
{"title":"Comment on \"The efficacy and safety of dapagliflozin in pediatric heart failure\".","authors":"Yuting Song, Qiang Shi, Chengzhi Xu","doi":"10.1016/j.ijcard.2025.133537","DOIUrl":"10.1016/j.ijcard.2025.133537","url":null,"abstract":"","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":" ","pages":"133537"},"PeriodicalIF":3.2,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144336499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信